首页> 外文期刊>P & T: a peer-reviewed journal for formulary management >Intravenous Versus Oral Acetaminophen in Ambulatory Surgical Center Laparoscopic Cholecystectomies: A Retrospective Analysis.
【24h】

Intravenous Versus Oral Acetaminophen in Ambulatory Surgical Center Laparoscopic Cholecystectomies: A Retrospective Analysis.

机译:静脉内与口腔乙酰氨基酚腹腔镜中心腹腔镜胆囊切除术:回顾性分析。

获取原文
获取原文并翻译 | 示例
           

摘要

The primary aim was to compare postoperative pain scores in patients undergoing laparoscopic cholecystectomy and receiving intravenous (IV) or oral (PO) acetaminophen (APAP) as part of a multimodal analgesic regimen to examine whether PO APAP is non-inferior to IV APAP. Retrospective analysis. Ambulatory surgical center (ASC) in an academic setting. 579 patients (18-70 years old), American Society of Anesthesiologists physical status I-III, undergoing laparoscopic cholecystectomy. Patients received 1,000 mg IV APAP intraoperatively (n = 319) or 1,000 mg PO APAP preoperatively (n = 260). The primary outcome was the median difference in post-anesthesia care unit (PACU) end-pain scores between the groups. Median pain scores were also compared on PACU admission, and at 15, 30, 45, and 60 minutes. Additional measures include PACU rescue-analgesia consumption, time to first PACU rescue analgesia, intraoperative use of opioid and nonopioid analgesics, PACU length of stay, and PACU rescue nausea and vomiting therapy. In both groups, the PACU median end-pain score was 2. The 90% confidence interval (CI) for difference in median pain scores between groups was [0, 0]; the CI upper limit was below the non-inferior margin of 1 pain-score point, indicating PO APAP's non-inferiority to IV APAP. There were no statistically significant differences in the percentages of patients receiving PACU hydromorphone equivalents between the IV and PO groups (75% vs. 77%, P = 0.72) or in the mean dose received (0.5 mg vs. 0.5 mg, P = 0.66). Single-dose PO APAP is non-inferior to IV APAP for postoperative analgesia in ASC laparoscopic cholecystectomy patients. The value of single-dose IV APAP in this population should be further explored.
机译:主要目的是将腹腔镜胆囊切除术和接受静脉注射(IV)或口服(PO)乙酰氨鸟(APAP)的术后疼痛评分作为多模式镇痛方案的一部分进行检查,以检查PO APAP是否非逊色于IV APAP。回顾性分析。在学术环境中的外科手术中心(ASC)。 579例患者(18-70岁),美国麻醉学士学学家身体状况I-III,正在进行腹腔镜胆囊切除术。患者术前(n = 319)或1,000mg po apap接受1,000mg IV Apap(n = 260)。主要结果是麻醉后护理单位(PACU)之间的中位数差异。在PACU入场和15,30,45和60分钟内也将中位疼痛评分进行比较。额外措施包括PACU救援 - 镇痛消费,前往PULU救援镇痛的时间,术中使用阿片类药物和非磷酸镇痛药,PACU的住宿时间和PACU救援恶心和呕吐治疗。在这两组中,PACU中位疼痛评分为2.群体疼痛分数差异的90%置信区间(CI)[0,0]; CI上限低于1个疼痛评分点的非较差余量,表明PO APAP对IV APAP的非劣势。在IV和PO基团接受PACU氢磷啡芯等当量的患者百分比没有统计学意义(75%vs.77%,p = 0.72)或接受平均剂量(0.5mg vs.0.5mg,p = 0.66 )。单剂量PO APAP是ASC腹腔镜胆囊切除术患者的术后镇痛的IV APAP。应进一步探索本人单剂量IV APAP的价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号